AOK Bayern Die Gesundheitskasse Tender

Contract notice: Open house drug discount agreements sorafenib, atc l01xe02 See description of procurementIt is not an open procedure, but a so-called open-house model! the form for the open procedure is only used because there is no form for the open-house model. contracts that are concluded in the open-house model are not subject to public procurement law due to the lack of a selection decision. the use of this form is not associated with submission to public procurement regulations. the aok bayern intends to enter into non-exclusive discount agreements with all interested pharmaceutical companies for the active ingredient sorafenib, atc l01xe02, in accordance with section 130a para. 8 sgb v to close. aok bayern offers all interested pharmaceutical companies that meet the eligibility requirements listed below the opportunity to conclude identical and non-individually negotiable discount agreements. The earliest possible contract start date is April 1st, 2022, all contracts end on March 31st, 2024. A contract can be concluded at any time during this period, but no later than February 5th, 2024. the contracts can be terminated with one months notice to the end of the month. When a nationwide or state-specific discount contract for drugs with the active substance that is the subject of the order comes into force, the open-house agreements automatically expire for the corresponding term. A contract is concluded with all interested pharmaceutical companies that prove their suitability by completing and signing their own declaration of reliability power of attorney) to send the contract along with completed Appendix 1 and Appendix 2 in 3 copies in the original as well as the completed and signed self-declaration of reliability in 1 copy to the following address: aok bayern - die Gesundheitskassevergabestelle sgb vze25open-house discount contractscarl-wery-str . 2881739 Munich, upon receipt of complete and correct documents by the 5th of each month, the contract begins on the first of the following month, otherwise on the first of the following month but one. Sending the complete, completed and signed documents in advance by fax (089/62730650151) or as a scan to the e-mail address vergabestelle1@by.aok.de is within the deadline if the complete and correct original documents in paper form are submitted by the 10th of the monthly at the aok bayern, allocation office. interested pharmaceutical companies can apply for the activation of the contract and the self-declaration of reliability in the project room for the open-house procedure on the portal www.dtvp.de. a link to the portal can be found in this announcement.